Methods of treating inflammatory disorders
OwnerJoshua Robert Schultz, Benedikt Vollrath +1inventors
InventorsJoshua Robert Schultz, Benedikt Vollrath, Court Turner
Life of this patent
Estimating the term…
Abstract
Disclosed herein, in certain embodiments, are methods and compositions for treating inflammatory disorders. In some embodiments, the methods comprise co-administering synergistic combinations of modulators of inflammation.
Claims13
A method of treating an inflammatory disorder, comprising co-administering to an individual in need thereof a synergistic combination of (a) a therapeutically-effective amount of a modulator of MIF selected from:
- (i) an agent that inhibits MIF binding to CXCR2 and CXCR4 and/or inhibits MIF-activation of CXCR2 and CXCR4;
- or (ii) an agent that inhibits the ability of MIF to form a homomultimer;
- and (b) a second active agent selected from an agent that treats an inflammatory disorder.
A pharmaceutical composition for modulating an inflammatory disorder, comprising a synergistic combination of (a) a therapeutically-effective amount of an agent that treats an inflammatory disorder;
- and (b) a therapeutically-effective amount of a modulator of MIF selected from:
- (i) an agent that inhibits MIF binding to CXCR2 and CXCR4 and/or inhibits MIF-activation of CXCR2 and CXCR4;
- or (ii) an agent that inhibits the ability of MIF to form a homomultimer.
Dependencies are inferred from the claim text.